Subscribe to our Email Alerts

Welcome

Why Invest in Amplia Therapeutics Limited

Amplia Therapeutics Limited (ASX: ATX) is developing new therapeutic options to treat patients with fibrotic diseases or cancer. By focusing on the key biological process of fibrosis, Amplia’s goal is to offer a better future for patients and families whose lives are impacted by these challenging diseases.

Email Alerts

Subscribe now for company news and be the first to get updates about the listing process.

 

Fact Sheet

View our fact sheet here.

 

Share Registry

Computershare Investor Centre